Investor Relations Director
ARCHIMED
Investor Relations Director
ARCHIMED
Healthcare-focused investment firm and strategic partner
ARCHIMED · Singapore, Singapore · Full-time · Posted 2026-10-06
Workplace: on_site
Department: Investor Relations
ABOUT ARCHIMED
With offices in Europe, the US and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare. Our mix of operational, medical, scientific and financial expertise positions us as both a strategic and financial partner to healthcare businesses. Priority areas include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools and Biologic Services, MedTech and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.
ARCHIMED manages $11 billion across its funds, including the largest healthcare-only private equity fund raised by a European-based GP. MED I, MED II and MED Platform I are all top-decile performers for their vintage according to Preqin data. Since inception, ARCHIMED has been a committed impact investor, both directly and through its EURÊKA Foundation.
THE TEAM
An international team (French, British, German, Polish, Canadian, US, Japanese) with complementary backgrounds across investment, medical, scientific, strategic and operational disciplines.
Alumni of INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, École des Ponts ParisTech, ESSEC, Imperial College and Dartmouth, among others.
Professional backgrounds spanning Private Equity (3i, Siparex, USS Ltd, Barings, Capiton, Partners Group), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC) and Industry (Biotronik, Cerba, pharmacy and veterinary).
THE ROLE
Reporting to the Head of Investor Relations, the Director of Investor Relations will play a leadership role in the strategic direction and execution of ARCHIMED's global capital formation and LP engagement efforts. This is a senior, high-visibility position with direct exposure to the firm's Partners and leadership, significant LP-facing responsibility and ownership of material components of the IR function.
FUNDRAISING LEADERSHIP
IR FUNCTION OWNERSHIP
CO-INVESTMENTS, GP-LED SECONDARIES AND STRATEGIC VEHICLES
Powered by Workable
ARCHIMED focuses on healthcare investing with offices in Europe, North America, and APAC. It provides strategic and financial backing using a blend of operational, medical, scientific, and financial expertise. The firm manages about €9 billion across funds and targets areas like Biopharma, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Services, and MedTech to help partners grow internationally, acquire, and innovate. Its goal is to support sustainable growth and positive health outcomes by funding and guiding healthcare companies, including impact investments through the EURÊKA Foundation.
Explore more opportunities at ARCHIMED